Pfizer says its oral Covid-19 pill can help prevent severe infection from the Omicron variant

Business Insider US
The Pfizer logo.

Pfizer announced Tuesday that lab studies show that its oral Covid-19 pill can help protect against severe disease from the novel coronavirus, including with the Omicron variant.

It cited data from lab studies involving high-risk patients.

"Final data available from all high-risk patients ... confirmed prior results of interim analysis showing PAXLOVID reduced risk of hospitalization or death by 89% (within three days of symptom onset) and 88% (within five days of symptom onset) compared to placebo; no deaths compared to placebo in non-hospitalized, high-risk adults with Covid-19," the statement said.

This story is developing. Please check back for updates.

Get the best of our site emailed to you every weekday.

Go to the Business Insider front page for more stories.